MK-0000-139

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-139, covering 2012-12-20 to 2012-12-20. Get the full timeline:

Most recent: Clinical Trial Update: 18F-FLT-PET in Breast Cancer (MK-0000-139) [Phase 2]